Literature DB >> 15708801

Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.

Mohammad S Ali1, S Rounaq Ali Khan, H Ojima, Ilse Y Guzman, Kenton H Whitmire, Zahid H Siddik, Abdul R Khokhar.   

Abstract

A series of platinum(II) and (IV) monoadducts of the type [Pt(II)(DACH)LCl]NO3 and [Pt(IV)(DACH)trans-(X)2LCl]NO3 (where DACH=trans-1R,2R-diaminocyclohexane, L=adenine, guanine, hypoxanthine, cytosine, adenosine, guanosine, inosine, cytidine, 9-ethylguanine (9-EtGua), or 1-methylcytosine and X=hydroxo or acetato ligand) have been synthesized and characterized by elemental analysis and by 1H and 195Pt nuclear magnetic resonance (NMR) spectroscopy. The crystal structure of the model nucleobase complex [Pt(IV)(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-EtGua)Cl]NO3.H2O was determined using a single crystal X-ray diffraction method. The compound crystallized in the monoclinic space group P2(1), with a=10.446(2) A, b=22.906(5) A, c=10.978(2) A, Z=4, and R=0.0718, based upon the total of 11,724 collected reflections. In this complex, platinum had a slightly distorted octahedron geometry owing to the presence of a geometrically strained five-member ring. The two adjacent corners of the platinum plane were occupied by the two amino nitrogen of DACH, whereas, the other two equatorial positions occupied by chloride ion and 9-ethylguanine. The remaining two axial positions were occupied by the oxygen atoms of acetato ligands. The DACH ring was in a chair configuration. An intricate network of intermolecular hydrogen bonds held the crystal lattice together. Some of these synthesized models of DACH-Pt-DNA adducts have good in vitro cytotoxic activity against the cisplatin-sensitive human cancer ovarian A2780 cell line (IC50=1-8 microM). Interestingly, a substituted nucleobase (9-ethylguanine) adduct was over 6-fold more potent than regular adducts. The cross-resistance factor against the 44-fold cisplatin-resistant 2780CP/clone 16 cells was about 3-9; thus, the cytotoxicity of adducts was indicative of low potency, but the resistance factors were also substantially low. These results suggest that DNA adducts of DACH-Pt are cytotoxic with low cross-resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708801     DOI: 10.1016/j.jinorgbio.2004.12.015

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides.

Authors:  Leticia Cubo; Ana M Pizarro; Adoración Gómez Quiroga; Luca Salassa; Carmen Navarro-Ranninger; Peter J Sadler
Journal:  J Inorg Biochem       Date:  2010-04-28       Impact factor: 4.155

2.  ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.

Authors:  S H Tonino; J van Laar; M H van Oers; J Y Wang; E Eldering; A P Kater
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

3.  Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.

Authors:  Sanne H Tonino; Chantal E Mulkens; Jacoline van Laar; Ingrid A M Derks; Guangli Suo; Fransien Croon-de Boer; Marinus H J van Oers; Eric Eldering; Jean Y Wang; Arnon P Kater
Journal:  Leuk Lymphoma       Date:  2015-01-21

4.  "Lantern-Shaped" Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt(2){HN=C(Bu)O}(4)L(2)](NO(3))(2).

Authors:  Concetta Pacifico; Francesco Paolo Intini; Fiorentin Nushi; Giovanni Natile
Journal:  Bioinorg Chem Appl       Date:  2010-06-08       Impact factor: 7.778

5.  Dysregulation of purine nucleotide biosynthesis pathways modulates cisplatin cytotoxicity in Saccharomyces cerevisiae.

Authors:  David Kowalski; Lakshmi Pendyala; Bertrand Daignan-Fornier; Stephen B Howell; Ruea-Yea Huang
Journal:  Mol Pharmacol       Date:  2008-07-08       Impact factor: 4.436

6.  Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.

Authors:  Mamoru Tanaka; Hiromi Kataoka; Shigenobu Yano; Hiromi Ohi; Keisuke Kawamoto; Takashi Shibahara; Tsutomu Mizoshita; Yoshinori Mori; Satoshi Tanida; Takeshi Kamiya; Takashi Joh
Journal:  BMC Cancer       Date:  2013-05-14       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.